Literature DB >> 21763008

Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II.

Sandy S Chang1, Carlos O Weiss, Qian-Li Xue, Linda P Fried.   

Abstract

Frailty is associated with a pro-inflammatory state, which has been characterized by elevated levels of systemic inflammatory biomarkers, but has not been related to the number of co-existing chronic diseases associated with inflammation. We sought to determine the extent to which a higher number of inflammatory-related diseases is associated with frailty and to identify the most common disease patterns associated with being frail in older adults. We performed binomial regression analyses to assess whether a higher count of inflammatory-related diseases increases the probability of frailty using data from the WHAS I and II, companion cohorts composed of 70-79-year-old community-dwelling older women in Baltimore, Maryland (n=620). An increase of one inflammatory-related disease was associated log-linearly with frailty (Prevalence Ratio (PR)=2.28, 95% Confidence Interval (CI)=1.81-2.87). After adjusting for age, race, education, and smoking status, the probability of frailty remained significant (PR=1.97, 95%CI=1.52-2.55). In the frail population, chronic kidney disease (CKD) and depressive symptoms (Prevalence=22.9%, 95%CI=14.2-34.8%); CVD and depressive symptoms (21.7%, 95%CI=13.2-33.5%); CKD and anemia (18.7%, 95%CI=11.1-29.7%); cardiovascular disease (CVD), CKD, and pulmonary disease (10.7%, 95%CI=5.2-21.0%); CKD, anemia, and depressive symptoms (8.7%, 95%CI=3.9-18.2%); and CVD, anemia, pulmonary disease, and depressive symptoms (5.0%, 95%CI=1.6-14.4%) were among the most frequent disease combinations. Their prevalence percentages were significantly higher in the frail versus non-frail women. A higher inflammatory-related disease count, perhaps reflecting a greater pro-inflammatory burden, increases the likelihood of frailty. Shared mechanisms among specific disease combinations may further contribute to this risk.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763008      PMCID: PMC3197795          DOI: 10.1016/j.archger.2011.05.020

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  54 in total

Review 1.  Cytokine pathways and joint inflammation in rheumatoid arthritis.

Authors:  E H Choy; G S Panayi
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

2.  Associations of subclinical cardiovascular disease with frailty.

Authors:  A B Newman; J S Gottdiener; M A Mcburnie; C H Hirsch; W J Kop; R Tracy; J D Walston; L P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 3.  Mechanisms activated by kidney disease and the loss of muscle mass.

Authors:  W E Mitch; S R Price
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

4.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

5.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

Authors:  Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried
Journal:  Arch Intern Med       Date:  2002-11-11

Review 6.  Aging and proinflammatory cytokines.

Authors:  H Bruunsgaard; M Pedersen; B K Pedersen
Journal:  Curr Opin Hematol       Date:  2001-05       Impact factor: 3.284

7.  Depressed mood and body mass index as predictors of muscle strength decline in old men.

Authors:  T Rantanen; B W Penninx; K Masaki; T Lintunen; D Foley; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-06       Impact factor: 5.562

8.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

9.  Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis.

Authors:  Rebecca Persinger; Yvonne Janssen-Heininger; Simon S Wing; Dwight E Matthews; Martin M LeWinter; Michael J Toth
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-02-11       Impact factor: 4.310

10.  Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

Authors:  Brad C Astor; Paul Muntner; Adeera Levin; Joseph A Eustace; Josef Coresh
Journal:  Arch Intern Med       Date:  2002-06-24
View more
  42 in total

1.  Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.

Authors:  Mara A McAdams-DeMarco; Andrew Law; Jingwen Tan; Cassandra Delp; Elizabeth A King; Babak Orandi; Megan Salter; Nada Alachkar; Niraj Desai; Morgan Grams; Jeremy Walston; Dorry L Segev
Journal:  Transplantation       Date:  2015-04       Impact factor: 4.939

Review 2.  Aging and chronic kidney disease: the impact on physical function and cognition.

Authors:  Shuchi Anand; Kirsten L Johansen; Manjula Kurella Tamura
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

3.  Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.

Authors:  C Berry; K K Poppe; G D Gamble; N J Earle; J A Ezekowitz; I B Squire; J J V McMurray; F A McAlister; M Komajda; K Swedberg; A P Maggioni; A Ahmed; G A Whalley; R N Doughty; L Tarantini
Journal:  QJM       Date:  2015-05-14

4.  Frailty and Access to Kidney Transplantation.

Authors:  Christine E Haugen; Nadia M Chu; Hao Ying; Fatima Warsame; Courtenay M Holscher; Niraj M Desai; Miranda R Jones; Silas P Norman; Daniel C Brennan; Jacqueline Garonzik-Wang; Jeremy D Walston; Adam W Bingaman; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-19       Impact factor: 8.237

5.  Regulatory T Cells, Frailty, and Immune Activation in Men Who Have Sex With Men in the Multicenter AIDS Cohort Study.

Authors:  Weiying Zhang; Tricia L Nilles; Jacquett R Johnson; Joseph B Margolick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-22       Impact factor: 6.053

Review 6.  Frailty in heart failure.

Authors:  Izabella Uchmanowicz; Maria Łoboz-Rudnicka; Przemysław Szeląg; Beata Jankowska-Polańska; Krystyna Łoboz-Grudzień
Journal:  Curr Heart Fail Rep       Date:  2014-09

7.  Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?

Authors:  Mathew S Maurer; Evelyn Horn; Alex Reyentovich; Victoria Vaughan Dickson; Sean Pinney; Deena Goldwater; Nathan E Goldstein; Omar Jimenez; Sergio Teruya; Jeff Goldsmith; Stephen Helmke; Melana Yuzefpolskaya; Gordon R Reeves
Journal:  J Am Geriatr Soc       Date:  2017-09-21       Impact factor: 5.562

8.  Nutritional status according to the mini nutritional assessment (MNA®) and frailty in community dwelling older persons: a close relationship.

Authors:  J Bollwein; D Volkert; R Diekmann; M J Kaiser; W Uter; K Vidal; C C Sieber; J M Bauer
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

9.  Frailty and Cognitive Function in Incident Hemodialysis Patients.

Authors:  Mara A McAdams-DeMarco; Jingwen Tan; Megan L Salter; Alden Gross; Lucy A Meoni; Bernard G Jaar; Wen-Hong Linda Kao; Rulan S Parekh; Dorry L Segev; Stephen M Sozio
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 8.237

Review 10.  Medication prescribing in frail older people.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Kenneth W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2012-09-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.